Login

Lucy Provenzano

ORCID: 0000-0002-2922-0109
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5014723589
Research Areas
  • Neurofibromatosis and Schwannoma Cases
  • Neuroblastoma Research and Treatments
  • Cell death mechanisms and regulation
  • Head and Neck Surgical Oncology
  • Phagocytosis and Immune Regulation
  • Cancer, Hypoxia, and Metabolism
  • Meningioma and schwannoma management
  • Hedgehog Signaling Pathway Studies
  • Cancer Research and Treatments

University of Plymouth
 2013-2016

 Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival
OPENALEX - Publications 
Sylwia Ammoun Lucy Provenzano Lü Zhou Magdalena Barczyk Kevin Gregory-Evans and 3 more David A. Hilton Sassan Hafizi C. Oliver Hanemann

10.1038/onc.2012.587 article EN Oncogene 2013-01-14
 Cellular prion protein (PrPC) in the development of Merlin-deficient tumours
OPENALEX - Publications 
Lucy Provenzano Yan Ryan David A. Hilton J Lyons-Rimmer Foram Dave and 5 more Emmanuel A. Maze Claire Adams R Rigby-Jones Sylwia Ammoun C. Oliver Hanemann

10.1038/onc.2017.200 article EN Oncogene 2017-07-10
 Abstract 4627: The role of human endogenous retroviral proteins in the development of Merlin-deficient tumors and as potential drug targets
OPENALEX - Publications 
Emmanuel A. Maze Shona Reeves David A. Hilton Lucy Provenzano Robert Belshaw and 1 more Sylwia Ammoun

Abstract Neurofibromatosis Type 2 (NF2) is a genetic disorder caused by loss of the tumour suppressor Merlin leading to development multiple tumours nervous system such as schwannomas, meningiomas and ependymomas. Merlin-deficient may also occur sporadically including all 50-60% 29-38% Loss functional have been observed in other e.g. mesothelioma, melanoma, portion glioma, prostate breast cancers. Current therapies for tumours, comprising surgery radiosurgery are invasive not fully effective...

10.1158/1538-7445.am2016-4627 article EN Cancer Research 2016-07-15
Coming Soon ...